Literature DB >> 3472989

Endogenous prostaglandin E2 in gastric mucosa of patients with alcoholic cirrhosis and portal hypertension.

T Arakawa, H Satoh, T Fukuda, H Nakamura, K Kobayashi.   

Abstract

The amount of prostaglandin E2 in endoscopic biopsy specimens from the mucosa of the gastric corpus and antrum of 10 healthy volunteers and 8 patients with alcoholic cirrhosis (7 of whom had portal hypertension) was measured by radioimmunoassay. The mean prostaglandin E2 level in both corpus and antral mucosa was significantly lower in the cirrhotic patients (p less than 0.025). Release of prostaglandin E2 into the gastric cavity was also significantly less in the cirrhotic patients in the basal state (p less than 0.025) and in that of tetragastrin stimulation (4 micrograms/kg, s.c.; p less than 0.01). There was no significant difference in acid secretion between the two groups of subjects. The histologic findings of biopsy specimens showed no difference in the extent of chronic gastritis between the cirrhotic patients and healthy subjects. Therefore, this deficiency of prostaglandin E2 in the gastric mucosa of cirrhotic patients was not related to acid secretion or chronic gastritis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3472989     DOI: 10.1016/0016-5085(87)90325-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  18 in total

Review 1.  Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome.

Authors:  K W Burak; S S Lee; P L Beck
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

2.  Gastric emptying in non-responders to H2-receptor antagonists.

Authors:  S Walker; J Meinke; U Klotz; G Treiber; J C Bode
Journal:  Klin Wochenschr       Date:  1990-10-03

3.  Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

Authors:  Mihajlo Gjeorgjievski; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2016-02-08

4.  Frequent non-response to histamine H2-receptor antagonists in cirrhotics.

Authors:  S Walker; D R Krishna; U Klotz; J C Bode
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

5.  Gastric mucosal resistance to acute injury in experimental portal hypertension.

Authors:  S Calatayud; M C Ramírez; M J Sanz; L Moreno; C Hernández; J Bosch; J M Piqué; J V Esplugues
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

6.  Gastric epithelial cell proliferation in patients with liver cirrhosis.

Authors:  A Zullo; A Romiti; V Rinaldi; A Vecchione; C Hassan; S Winn; S Tomao; A F Attili
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

7.  Diffuse vascular ectasia of the antrum, duodenum, and jejunum in a patient with nodular regenerative hyperplasia. Lack of response to portosystemic shunt or gastrectomy.

Authors:  P Calès; J J Voigt; J L Payen; E Bloom; P Berg; J P Vinel; B Pradère; P Broussy; J P Pascal
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

8.  Mucosal lesions of the stomach in liver cirrhosis with a special reference to phospholipid metabolism.

Authors:  Y Hosokawa
Journal:  Gastroenterol Jpn       Date:  1991-06

9.  Peptic ulcer surgery in patients with liver cirrhosis.

Authors:  T Lehnert; C Herfarth
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

10.  Effects of zinc L-carnosine on gastric mucosal and cell damage caused by ethanol in rats. Correlation with endogenous prostaglandin E2.

Authors:  T Arakawa; H Satoh; A Nakamura; H Nebiki; T Fukuda; H Sakuma; H Nakamura; M Ishikawa; M Seiki; K Kobayashi
Journal:  Dig Dis Sci       Date:  1990-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.